SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains

标题
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains
作者
关键词
CDK8 mediator, kinase inhibitor, STAT5, AML, leukemia stem cells
出版物
Oncotarget
Volume 8, Issue 20, Pages -
出版商
Impact Journals, LLC
发表日期
2017-04-04
DOI
10.18632/oncotarget.16810

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started